RxDoctor Payments Data

Jodi Winkel, MD

Family Medicine · Garner, NCNPI 1114988789

Payments from drug & device makers

$4,890in general payments, 2019–2025

Across 279 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Boehringer Ingelheim$494
  • AbbVie$329
  • Lilly USA, LLC$306
  • Amgen$256
  • Bausch Health US, LLC$226
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$4,868100%
  • Education$220%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,890 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$126,175
Medicare patients
175
Services billed
3,193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide315$355,547
EliquisApixaban75$61,205
RybelsusSemaglutide53$58,481
JardianceEmpagliflozin44$44,003
TrulicityDulaglutide24$31,372
JanuviaSitagliptin Phosphate53$31,085
MounjaroTirzepatide26$30,913
MyrbetriqMirabegron44$27,139
LinzessLinaclotide34$26,837
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$23,201
SynthroidLevothyroxine Sodium164$16,436
Praluent PenAlirocumab22$15,673
WegovySemaglutide12$15,421
BelsomraSuvorexant29$14,747
Repatha SureclickEvolocumab19$13,725

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Wegovy$1,327$429,449380 claims
PfizerEliquis, Levoxyl$161$63,693126 claims
Lilly USA, LLCTrulicity, Mounjaro$306$62,28550 claims
AbbVieLinzess, Synthroid, Qulipta, Fetzima$329$61,783222 claims
MerckJanuvia, Belsomra$90$45,83282 claims
Boehringer IngelheimJardiance$494$44,00344 claims
Astellas Pharma US IncMyrbetriq$34$27,13944 claims
GSKTrelegy Ellipta, Arnuity Ellipta$47$26,56938 claims
Johnson & JohnsonXarelto$95$10,48411 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$86$10,43420 claims
AstraZenecaSymbicort$201$6,19422 claims
Eisai Inc.Dayvigo$17$4,85213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Garner

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →